Thousands of men with prostate cancer will be denied life-extending drug
Thousands of men with prostate cancer will be denied life-extending drug after health experts ruled it was not cost effective Life-extending drug for advanced prostate cancer patients was not approved Abiraterone gives patients extra 15 months on average and cuts the risk of them dying within three years by a third Institute which approves NHS drugs ruled … Read more